Short-Seller Pami Qudir Targets South Korea's Undervalued Equities, Two-Thirds Below Book Value
According to the Wall Street Journal on July 19, activist investor Pami Qudir, known for his short-selling success against Valeant Pharmaceuticals and Wirecard, is shifting strategy to invest in South Korean companies. Based in London, Qudir is now scouting holdings across undervalued mid-cap
GateNews·07-20 04:07
